illumina patent expiration

Reach him at blake.brittain@thomsonreuters.com. If youd like to retain your premium access and save 20%, you can opt to pay annually at the end of the trial. Try full digital access and see why over 1 million readers subscribe to the FT, Purchase a Trial subscription for $1 for 4 weeks, You will be billed $69 per month after the trial ends, Russian far-right fighter claims border stunt exposes Putins weakness, Something is boiling: Turkish football fans tackle Erdoan, Three-day weekends and more time for love: Chinas elite dream up policies for Xi, Germany and Italy stall EU ban on combustion engines, Feds Daly says US rates likely to be higher for longer, Saudi owner of Londons most expensive house sued over alleged unpaid private jet bills, Why the Jeffrey Epstein scandal continues to haunt JPMorgan and Barclays, US electric vehicle batteries poised for new lithium iron age. This is the first time the UK patent courts have truly grappled with sufficiency at a lower instance. Illumina invented its 2-channel technology before the BGI patents, and BGI was unable to make 2-channel chemistry work until it copied Illuminas technology, the spokesperson said in a statement. European patent attorney Philippa Griffin of Mathys & Squire appeared as a strawman in the appeal hearing. Cookie Details We do not anticipate that this decision will affect our ability to supply and service our customers.. The case centers on 2019 lawsuit filed by Complete Genomics a U.S. subsidiary of Chinese genomics company BGI Group. The European patent attorney also regularly files patents for the US company at theEPO. To contact the reporter on this story: Christopher Yasiejko in Wilmington, Del., at cyasiejko@bloombergindustry.com, To contact the editors responsible for this story: Rob Tricchinelli at rtricchinelli@bloomberglaw.com; Steven Patrick at spatrick@bloomberglaw.com, Learn more about a Bloomberg Law subscription. Illumina makes ~10x on consumables. Illumina Inc. owes BGI Group, the world's largest maker of commercial genetic sequencers, $333.8 million after a federal jury in Delaware found Friday that some of its DNA sequencing systems infringe two patents related to technology that deduces each nucleotide's identity from two signals. The Illumina In-Licensed Patents as of the Effective Date are set forth on Annex II, provided that on and after the Effective Date, the Patents set forth on Annex IV (in-licensed by Sequenom from CUHK) shall be deemed added to Annex II, and Annex IV shall be deemed to no longer include any Patents. The trial began April 25 and featured competing allegations that each companys DNA sequencing systems infringe the others patents. You can give your consent to whole categories or display further information and select certain cookies. As of right now, it seems that Illuminas original cluster generation IP has expired (from Manteia) has expired. During your trial you will have complete digital access to FT.com with everything in both of our Standard Digital and Premium Digital packages. The jury's verdict follows the decision of Judge William Orrick, in the same case, to award Illumina summary judgment on claims of infringement by BGI's StandardMPS and CoolMPS products. At the very least MGI will be unblocked from selling instruments in the US. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Some was asking on Twitter about the effect of Illuminas IP expiring on the sequencing industry. A technician uses an Illumina Inc. DNA sequencing machine at the Li Ka Shing Institute of Health Sciences at the Chinese University of Hong Kong in Hong Kong, China, on June 20, 2017. The listed products and their use are the subject of the following US Patent Nos. Well, I expect prices to do down, but I wouldnt expect Illumina to solely compete on price. 2020 preliminary results: Illumina said it finished last year with about $4.517 billion in revenue, up 39% from 2020, including about $1.19 billion in fourth-quarter revenue, up 25% over. Each company sought a reasonable royalty for the alleged infringement of its patents by certain features of the accused products. You can find out more about which cookies we are using or switch them off in settings. Illumina's shares dropped sharply following the verdict but have rebounded somewhat since. Gene sequence giant Illumina is weighing its next moves after a federal jury in Delaware found the San Diego company infringed on two patents from a rival genomics company and awarded $334 million in damages. Hide Cookie Information. travels to Asia to strengthen business ties, How major US stock indexes fared Friday 3/3/2023, VMware, Broadcom rise; Marvell, Bumble fall. Try our Advanced Search for more refined results. Retailer Reg: 2019--2018 | 10,480,025, titled "Labelled nucleotides"while . The Biden administration is close to tightening rules on some overseas investments by American companies, A Volkswagen Group-backed automotive company announced plans this week to open a $2 billion electric truck and SUV manufacturing plant just outside of Columbia, South Carolina, Oklahoma voters are deciding whether to legalize marijuana sales for those 21 and older. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Analysts say the bad news is prompting investors to question the company's strategy of buying Grail, which Illumina forecasts will generate an operating loss of $670mn in 2023 on revenues of. "BGI has brazenly copied Illumina's proprietary sequencing chemistry. Those patents werent part of the Delaware case. See here for a complete list of exchanges and delays. All quotes delayed a minimum of 15 minutes. 249 0 obj <>/Filter/FlateDecode/ID[<6552C99E7534134FBECC31BE4AF41116>]/Index[229 30]/Info 228 0 R/Length 101/Prev 92673/Root 230 0 R/Size 259/Type/XRef/W[1 3 1]>>stream 2023 Illumina, Inc. All rights reserved. As of right now, it seems that Illumina's original cluster generation IP has expired (from Manteia) has expired. Any changes made can be done at any time and will become effective at the end of the trial period, allowing you to retain full access for 4 weeks, even if you downgrade or cancel. A jury recently invalidated Illumina's U.S. Patent No. Opponents included strawmen as well as Qiagen, a Germany-based provider of DNA sequencing technology. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. Theyre iterated over the original IP pretty well and have a number of other advantages over new players specifically: This is all technology was developed for Hiseqs and later instruments. 7,541,444, titled "Modified nucleotides," and claim 1 of U.S. Patent No. The patents in that case expire in August 2022 and January 2023. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. We use cookies and other technologies on our website. We use cookies and other technologies on our website. 7,541,444 (the '444 Patent) and U.S. Patent No. These two patents appear to be the fundamental IP required to build an Illumina-style DNA sequencer. As a result, companies are now fighting hard for market share in this cutting-edge technology. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. This week, the EPO Boards of Appeal rejected Illuminas appeal concerningEP 2 325 304(T2248/14-3.3.08), resulting in the loss of the patent. Illumina have a number of polymerase patents. Illumina was represented by Colm Murphy, London partner of US law firm Cooley. Cookie by Google used to control advanced script and event handling. We use cookies on our website. Additionally, Natera has granted Illumina a non-exclusive license to Natera's '592 Patent family. Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts. You can revoke or adjust your selection at any time under Settings. Illumina has won a patent infringement suit in the UK against defendant MGI over DNA sequencing technology. offers FT membership to read for free. Privacy Policy Im not a patent lawyer, so you should consider that when evaluating my thoughts. Q. Here you will find an overview of all cookies used. In 2010, Illumina filed a complaint in California against Complete Genomics, an MGI subsidiary, alleging that the company infringed on three of its DNA sequencing patents with the latter companys Complete Genomics Analysis Platform. In response, Complete Genomics asserted that Illumina had attempted to achieve monopoly power in genome sequencing technology.. It is Illumina's policy to seek patent protection in the United States and abroad for such technology and products. df-mp Drries Frank-Molnia & Pohlman Patentanwlte Rechtsanwlte PartG mbB, filed apatent infringement counterclaim against Illumina, https://policies.google.com/privacy?hl=en, https://www.hotjar.com/legal/policies/privacy/, https://www.facebook.com/privacy/explanation, https://policies.google.com/privacy?hl=en&gl=en, https://wiki.osmfoundation.org/wiki/Privacy_Policy. Thousands of warm hubs have sprouted across Britain as high energy bills fuel a cost-of-living crisis, The No. In addition, although Complete Genomics may seek an injunction, we do not believe there is a reasonable basis for the court to grant one, said Illumina in the filing. BGI Group, a genome sequencing company based in China, on Monday escalated its global intellectual property fight with rival Illumina Inc by filing a U.S. patent case against the California-based . You can find more information about the use of your data in our, You can revoke or adjust your selection at any time under. You may occasionally receive promotional content from the San Diego Union-Tribune. university %%EOF The Court found that four of the five asserted patents were valid and . The reversible terminator IP has not theyre currently using this IP to block the sale of some MGI instruments. DNA Sequencing is Universal Sensing, Mitutoyo Digimatic 500-133U CDL-6B Battery Cover Model, NEC Teledata Terminal Shop Register (TD7), Motorboard Easydriver/Arduino/PKE243DA interface r1, Veeco Nanoscope V Multimode AFM First Imaging Tests, Axopatch 200A with micropipette first tests, Playing with a micropipette puller (Sutter P-97), Couldnt remount RDWR because of unprocessed orphan inode list. Show Cookie Information The reversible terminator IP has not they're currently using this IP to block the sale of some MGI instruments. Illumina invented its 2-channel technology before the BGI patents, and BGI was unable to make 2-channel chemistry work until it copied Illuminas technology, said the company is a statement. Justia Patents Patents Assigned to Illumina Patents Assigned to Illumina LAMINATE FLUIDIC CIRCUIT FOR A FLUID CARTRIDGE Publication number: 20230048094 Abstract: An apparatus includes a fluid reservoir and a laminate fluidic circuit positioned above the fluid reservoir. The case is Complete Genomics Inc. v. Illumina Inc., D. Griffins clients include New England Biolabs and the Ecole Polytechnique Fdrale De Lausanne (EPFL). So the cluster and nucleotide IP are really the key to producing an Illumina-style DNA sequencer. Orrick also issued a permanent injunction blocking BGI from selling CoolMPS products in the U.S. until after Aug. 23, when the only valid patent at issue against that sequencer will have expired. This is Not an Article on Data Protection and Competition Law. Illumina MiSeq Dx Cystic Fibrosis Assays, TruSeq Stranded total RNA Sample Prep Kits, BaseSpace Cohort Analyzer Related Products, BaseSpace Variant Interpreter Related Products, BaseSpace Correlation Engine Related Products. Host: https://www.illumina.com | But my understanding is that the 9N (9 degrees North) and related polymerases incorporate modified nucleotides pretty well. And I suspect companies like Element are working on something similar. Accept all Please umount/remount instead, LTC1859 8 Channel, 100KSPS +/- 10V 16bit ADC Arduino Shield layout, AD5791 20Bit DAC Evaluation board with Arduino, LTC1859CG Evaluation board with an Arduino, Cheap Z-stage (SELN LZ-60 Shengling Precise Machinery CO. Ltd), Fractal Slippy Map in golang and LeafletJS, Serving server generated PNGs over HTTP in golang, Kindlegen, W14001: Hyperlink not resolved errors, hp t5325 thin client information and manuals, HY-DIV268N-5A Stepper driver with Arduino, Most common git screwups/questions and solutions, Select random line from a file in a single pass, Serving gziped connect via HTTP in golang, USRP1 simple data capture in C++ example (UHD), Some simple Arduino code to read from a keypad, Using the Arduino tools from the Linux command line, Simple JS->DNS Proxy with golang server side, MSP430Watch2 Barometer and Wifi (PCB Design), Creating an SVG in Javascript using FabricJS and downloading it locally, Creating an SVG in Javascript, trivial example, Kicad Gerber renaming script for OSHPark (and seeed etc) submission, Anritsu MT8815b Radio Communication Analyzer Notes, esp8266 writing to internal flash (basic key/value store), Accepting incoming tcp connections on the esp8266 (trivial example), A standalone sscanf implementation (for the esp8266), Installing Nagios on Debian Jessie and SNMP (UPS) monitoring, Posting to the Safecast API from the esp8266, esp8266 client mode (connect to remote host) simple example, Gorilla Websockets, golang simple websockets example, Getting to awa-kamogawa from Tokyo by train, Emscripten calling JS from C and returning by reference (pointer), Calling JS from C using EM_ASM in Emscripten, Compiling OpenSSL and libssh2 with emscripten notes, Sony/Tektronix 3066 DC-3GHz Realtime spectrum analyzer, Astable multivibrator RGB flasher PCB design, A Common Emitter Hartley Oscillator Notes, Logitec LBT-VRU01 (bluetooth LE iPhone locator? You can revoke or adjust your selection at any time under Settings. Overall, several patent disputes relating to Illuminas DNA sequencing technique are still pending at the EPO. Previously, Illumina said that US Patent No. Illumina's stock was down more than 14% Friday following the verdict. If you disable this cookie, we will not be able to save your preferences. Harrods chief shrugs off recession fears because rich get richer, FCA regulator blamed for Arms decision to shun London listing, Argentina diary: Come armed with $100 bills, There are no domestic equity investors: why companies are fleeing Londons stock market, Clutching Warrens letter, Im still positive on stocks, The Murdaugh trial: a southern gothic tale that gripped the nation, Humanity is sleepwalking into a neurotech disaster, Who to fire? Then theyll let other players take the low end of the market and try and keep the high end where margins are higher (and users are willing to pay for slightly better data quality). Save The European Patent Office has destroyed several patents belonging to Illumina, a US manufacturer of genetic engineering equipment. In addition, the EPO revoked patents EP 2 338 893 and EP 1 451 351 B1from a patent family for labelled nucleotides. Personal data may be processed (e.g. This means that every time you visit this website you will need to enable or disable cookies again. Please see our Privacy Policy. Some of them are essential, while others help us to improve this website and your experience. As always there are niches to play in (base modifications, long reads etc.) Further strawmen were patent attorney Leo Polz and Christian Kilger. other approaches on the market or in development. In the legal profession, information is the key to success. No one on our HOA board has been elected and they all remain on by default year after year. Great! In a later Delaware case, Complete Genomics accused Illumina of infringing on its own patents with two-channel sequencing systems, kits to prepare DNA fragments for sequencing and kits to immobilize, amplify and sequence fragments. hb```v eah`hje0sDt'j;:*:::$ np4p&~P%CH@| .Hibe`1Fq10f@$` !1 Saves the visitors preferences selected in the Cookie Box of Borlabs Cookie. Illumina Inc. owes BGI Group, the worlds largest maker of commercial genetic sequencers, $333.8 million after a federal jury in Delaware found Friday that some of its DNA sequencing systems infringe two patents related to technology that deduces each nucleotides identity from two signals. Of course there are other approaches on the market or in development. Reuters, the news and media division of Thomson Reuters, is the worlds largest multimedia news provider, reaching billions of people worldwide every day. %PDF-1.5 % You may change or cancel your subscription or trial at any time online. Some of them are essential, while others help us to improve this website and your experience. The two patents cover technology fornext generation sequencing and were revoked due to formal errors. New configurations will bring longer read capabilities with more output for immune repertoire, shotgun metagenomics and more, Discover novel trait and disease associations with optimized tag SNPs and functional exonic content at an attractive price, DRAGEN v4.0 release enables machine learning by default, providing increased accuracy out of the box, Our instrument performance service helps reduce unplanned downtime and minimize instrument requalification, Robust methylation profiling microarray with extensive coverage of CpG islands, genes, and enhancers, Two DRAGENs help Cardio-CARE slay one petabyte of data to better understand heart disease in Hamburg, Together, were finding answers to lifes biggest questions and broadening the positive impact of genomics around the world, Get instructions for using Illumina DRAGEN Bio-IT Platform v4.0, Enable comprehensive genomic profiling with accurate and comprehensive homologous recombination deficiency assessment, Save on the Ribo-Zero Plus Microbiome rRNA Depletion Kit, restrictions apply, A multi-species, low-cost, genome-wide genotyping platform to support molecular breeding in small grains, A comprehensive, easy-to-implement, and versatile genomic analysis tool set for translational researchers, The NovaSeq 6000Dx is our first IVD-compliant high-throughput sequencing instrument for the clinical lab. It uses mutant DNA polymerase enzymes in nucleic acid sequencing reactions, which is particularly important for sequencing-by-synthesis. Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology. SAN DIEGO-- (BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) today announced that the High Court of Justice, Chancery Division, Patents Court, issued a judgment in its favor in the patent infringement suit filed against the BGI Companies, MGI Tech Co. Ltd; Latvia MGI SIA; MGI International Sales Co., Ltd; and BGI Complete Genomics Hong Kong Co., organisation qPCR dominates here because the COGS for qPCR is essentially $1 and the COGS or instruments a few hundred. BGI Group is the corporate parent of both MGI, Complete Genomics owner, and of BGI Genomics. If External Media cookies are accepted, access to those contents no longer requires manual consent. Simmons + Simmons LLP. ), Illumina Win Over BGI Upheld as Judge Blocks Gene Sequencers (2), Illumina, BGI Trim Patent Claims as Another Jury Trial Looms, BGI Asks For New Patent Trial After $8 Million Loss to Illumina, BGI Must Pay Illumina $8 Million in Gene-Sequencing Patent Spat, Complete Genomics Inc. v. Illumina Inc. (D. ), NPN Common Collector, Colpitts oscillator notes, NPN BJT Common emitter inverting amplifier, Simple example of SDL in Emscripten (generating graphics from C), Phase Shift Oscillator High Pass configuration, Astable multivibrator oscillator and a little oscillator history, Driving a tiny stepper on an Arduino (without a driver! (Reuters) - Illumina Inc and BGI Group's MGI Tech Co and Complete Genomics have settled U.S. litigation over their rival DNA-sequencing technology, the companies said Thursday. Patents. The above analysis relies on the fact that the COGS of competitors is probably going to be similar to Illumina. Filed under Sequencing Business News Asia/Oceania lawsuit North America Tripadvisor picks two for top 10 in U.S. Endlessly curious La Jolla architect Eugene Ray still learning, imagining and creating at 90, Electric cars: More consumers now want to buy them, survey says, Boeing CEO loses $7M bonus, keeps $22.5 million compensation, Fashion Valley is getting a resort-style makeover, Ukraine ally Kallas fights for reelection in Estonia vote, Global race to boost electric vehicle range in cold weather, Paid express lanes grow more popular in once-reluctant South, Louisiana Gov. An Illumina spokesperson said the company plans to appeal and that the verdict should not affect its ability to supply its customers. Hotjar is an user behavior analytic tool by Hotjar Ltd.. We use Hotjar to understand how users interact with our website. Compare Standard and Premium Digital here. Imprint. Get U-T Business in your inbox on Mondays. analyse how our Sites are used. Subscribe to CPIs free daily newsletterfor more headlines and updates on antitrust developments around the world. Can Shell close the valuation gap with US rivals? IP addresses), for example for personalized ads and content or ad and content measurement. Illumina's '973 patent is expected to expire in 2023 and the '444 patent in 2024. Illumina has sought to stay ahead by expanding its portfolio of sequencers. or But in May, a Delaware jury decided that Illumina owes Complete Genomics more than $333 million for infringing on two patents, court documents state. Cooley (London): Colm Murphy, For Qiagen and as a strawman The company also filed an anticompetitive suit against Illumina in Delaware last year. After spending the last 10-plus years in court, Illumina and BGI Group have reached a $325 million settlement to resolve a number of patent and antitrust claims across the US centered around the companies DNA sequencing technology. Hardware (Instrument) Hardware will conform to Illumina's specifications for 12 months after shipment from Illumina. Judge William H. Orricks March 27 order in the U.S. District Court for the Northern District of California resolved a spate of issues in two suits between the rivals, including by its denial of BGIs bid for a new trial. Please see our Privacy Policy. Analysts say the bad news is prompting investors to question the company's strategy of buying Grail, which Illumina forecasts will generate an operating loss of $670mn in 2023 on revenues of. It has the same estimated expiration as the first patent. Essentially for everything else available or on the horizon the data quality is not as good and COGS is higher than the Illumina approach. Here you will find an overview of all cookies used. The stock closed Friday up 7.4. Well, for a start I expect it to put downward pressure on Illuminas consumable pricing. Tax Reg: 105-87-87282 | You can give your consent to whole categories or display further information and select certain cookies. Limited Use Label License: This product and its use are the subject of one or more issued and/or pending US and foreign patent applications owned by Max Planck Gesellschaft, exclusively licensed to New England Biolabs, Inc. and sublicensed to Illumina, Inc. Del., No. Some of them are essential, while others help us to improve this website and your experience. 7, 771,973, titled "modified nucleotides" will expire in August 2022. Competitors in this market include the German company Qiagen and the Chinese manufacturer of genetic sequencers BGI Group, as well as MGI. If you do nothing, you will be auto-enrolled in our premium digital monthly subscription plan and retain complete access for $69 per month. and other data for a number of reasons, such as keeping FT Sites reliable and secure, Some of them are essential, while others help us to improve this website and your experience. N choose K, with T targets. The European Patent Office has destroyed several patents belonging to Illumina, a US manufacturer of genetic engineering equipment. The nearly $1 million Novaseq 6000 is expected to one day unlock the $100 genome. Complete Genomics is represented by Young Conaway Stargatt & Taylor LLP and Quinn Emanuel. The latest of these patents is due to expire in 2024. Some of them are essential, while others help us to improve this website and your experience. This latest settlement should put an end to the storm of lawsuits at least for a while. 7,566,537 and 9,410,200. Scripts to download SARS-CoV-2 replacements, Sony CCD-V8AF Video Camera Recorder Viewfinder CRT Notes, Playing with a Handycam CCD-F340 Viewfinder CRT Notes, Thoughts on a new approach to viral testing, Quick script to download Uniprot info for proteins from Pfam trees (Newick tree format), Notes on fixing a broken Gentoo grub install, Notes on using a ILX511 Linear CCD, AD9225 ADC, ICE40HX8K and Nmigen, Thoughts on interviewing with YC as a science based startup, 2018 DNA Sequencing Raises and Acquisitions. The license is limited to Illumina's current technology used for massively parallel sequencing in . The companies have been embroiled in a global legal battle over their respective sequencing technologies, with court cases in countries including Germany, Denmark, Switzerland, and Turkey. It also targeted Illuminas library preparation kits and cluster generation and sequencing kits compatible with one or more of the systems, according to court papers. In particular its been disappointing to see the limited impact of sequencing on SARS-CoV2 diagnostics. 287(a) for the following products: Infrastructure New Study: China Overtakes US In Competition For Key Emerging Tech, Mexico Issues Highest-Ever Gun-Jumping Penalty. The industry leader for online information for tax, accounting and finance professionals. For cost savings, you can change your plan at any time online in the Settings & Account section. 5,964,443 and 6,437,109, European Patent No 0927258 and related patents and patent application licensed from the Wisconsin Alumni Research Foundation. For a full comparison of Standard and Premium Digital, click here. Check if your Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Change the plan you will roll onto at any time during your trial by visiting the Settings & Account section. You can still enjoy your subscription until the end of your current billing period. We are using cookies to give you the best experience on our website. | Back in November, a federal jury ruled that four of Illuminas five patents in the California case were valid, awarding it $8 million, according to a Law360 report. Law360 takes your privacy seriously. Illumina, a publicly traded company based in San Diego with more than $3.2 billion in revenue in 2020, claimed that BGI and its subsidiaries willfully infringed five of its patents related to. The listed products and their use are the subject of US Patent Nos. 229 0 obj <> endobj 10,480,025 (the '025 Patent) asserted against BGI in the suit, which are directed to blocked CH Kilger (Berlin): Christian Kilger, Strawman Photodiode Amplifier Board, Photobeaching on the Genome Analyzer, using a IMX178, Single Dye Experiments on a Genome Analyzer, Genome Analyzer Quantum GEM 532nm Laser and filters. I figured Id summarize my thoughts here. It also bars U.S. sales of StandardMPS products through Jan. 21, 2023. The DNA sequencing patents are interesting for competitors such as MGI and the BGI Group, which are also in the midst of patent infringement claims. by The DNA sequencing patents are interesting for competitors such as MGI and the BGI Group, which are also in the . Illumina contends the verdict is not supported by the evidence presented at trial. But it will be short lived. So I expect Illumina to maintain a quality advantage. Tesla recalls 3,470 Model Y vehicles over loose bolts, Exclusive: Nvidia's plans for sales to Huawei imperiled if U.S. tightens Huawei curbs-draft, Reporting by Blake Brittain in Washington; additional reporting by Raghavi Kasa; Editing by David Gregorio and Diane Craft, Mexico can't match U.S. incentives for proposed Tesla battery plant, minister says, Taiwan's TSMC to recruit 6,000 engineers in 2023, Twitter's revenue, adjusted earnings drop about 40% in December - WSJ, Exclusive news, data and analytics for financial market professionals. endstream endobj startxref Cookie by Google used for website analytics.